Emergence of the E484K Mutation in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lineage B.1.1.345 in Upstate New York

Authors

Emil Lesho, Rochester Regional HealthFollow
Brendan Corey, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland
Francois Lebreton, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland
Ana C. Ong, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland
Brett E. Swierczewski, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland
Jason W. Bennett, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland
Edward E. Walsh, Rochester Regional HealthFollow
Patrick Mc Gann, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland

Department

Infectious Diseases

Document Type

Article

Publication Title

Clinical Infectious Diseases

Abstract

A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.345 variant carrying the E484K mutation was detected in 4 patients with no apparent epidemiological association from a hospital network in upstate New York. Subsequent analysis identified an additional 11 B.1.1.345 variants from this region between December 2020 and February 2021.

First Page

909

Last Page

912

DOI

10.1093/cid/ciab507

Volume

74

Issue

5

Publication Date

3-1-2022

PubMed ID

34086878

Recommended Citation

Lesho, E., Corey, B., Lebreton, F., Ong, A., Swierczewski, B. E., Bennett, J. W., Walsh, E. E., & Gann, P. (2022). Emergence of the E484K Mutation in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lineage B.1.1.345 in Upstate New York. Clinical Infectious Diseases, 74 (5), 909-912. https://doi.org/10.1093/cid/ciab507